Healthcare Oct 22, 2021 09:32 AM (GMT+8)
The clinical mass spectrometry enterprise "Pinsheng medicine" recently completed a new round of financing of hundreds of millions of yuan, and introduced institutional investors such as Dazheng capital and Tongchuang Weiye. After this round of financing is completed, Pinsheng medicine will accelerate its R & D and commercialization process. The newly raised funds will be used to expand the market and increase R & D, promote the localization of clinical mass spectrometry equipment and the development of relevant diagnostic reagents, and expand factories, laboratories and other infrastructure.
This text is a result of machine translation.